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Abstract
Susceptibility to bovine respiratory disease (BRD) is multi-factorial and is influenced by
stress in conjunction with infection by both bacterial and viral pathogens. While vaccina-
tion is broadly used in an effort to prevent BRD, it is far from being fully protective and
cases diagnosed from a combination of observed clinical signs without any attempt at
identifying the causal pathogens are usually treated with antibiotics. Dairy and beef cattle
losses from BRD are profound worldwide and genetic studies have now been initiated to
elucidate host loci which underlie susceptibility with the objective of enabling molecular
breeding to reduce disease prevalence. In this study, we employed RNA sequencing to
examine the bronchial lymph node transcriptomes of controls and beef cattle which had
individually been experimentally challenged with bovine respiratory syncytial virus, infec-
tious bovine rhinotracheitis, bovine viral diarrhea virus, Pasteurella multocida,Mannhei-
mia haemolytica orMycoplasma bovis to identify the genes that are involved in the bovine
immune response to infection. We found that 142 differentially expressed genes were
located in previously described quantitative trait locus regions associated with risk of
BRD. Mutations affecting the expression or amino acid composition of these genes may
affect disease susceptibility and could be incorporated into molecular breeding programs.
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Genes involved in innate immunity were generally found to be differentially expressed
between the control and pathogen-challenged animals suggesting that variation in these
genes may lead to a heritability of susceptibility that is pathogen independent. However,
we also found pathogen-specific expression profiles which suggest that host genetic varia-
tion for BRD susceptibility is pathogen dependent.
Introduction
Bovine respiratory disease (BRD) is the most significant health problem faced by feedlots
worldwide and is responsible for 70–80% of morbidities and 40–50% of mortalities in the
United States [1]. The precise cost of BRD to the industry is not well understood [2], but losses
of at least $1 billion annually have been estimated considering costs of prevention, treatment,
loss of productivity and labor [3]. Despite BRD being one of the most common and expensive
diseases of feedlot cattle, annual morbidity and mortality rates have increased despite the
extensive use of vaccines and antimicrobials [4]. BRD is caused by a number of bacterial and
viral pathogens which are collectively referred to as the bovine respiratory disease complex
(BRDC). This complex includes bovine herpes virus type 1 also known as infectious bovine rhi-
notracheitis (IBR), bovine parainfluenza type 3 virus (PI3), bovine viral diarrhea virus
(BVDV), bovine respiratory syncytial virus (BRSV), and bacterial pathogens Arcanobacterium
pyogenes,Mannheimia haemolytica, Pasteurella multocida,Histophilus somni andMycoplasma
bovis [5]. However, the onset of disease is usually associated with environmental stressors, a
susceptible host and the presence of both viral and bacterial pathogens [4].
Stress resulting from management procedures can predispose calves to an initial infection
by a viral pathogen which may suppress the animals’ defense mechanisms, facilitating a sec-
ondary infection due to the colonization of the lower respiratory tract by bacteria [6]. While
respiratory viruses are capable of causing a clinical disease that is consistent with BRD in the
absence of a bacterial co-infection [7], viral infection is usually considered to be the precursor
to a secondary bacterial infection which leads to the disease syndrome of BRDC [6,8].
Although the importance of many environmental and management stress factors, such as
weaning and transportation are well understood, as is the fact that susceptibility to BRD is
lowly to moderately heritable [9], the genetic dissection of the specific loci underlying suscepti-
bility has yet to be tackled. Two approaches are commonly used either individually, or in con-
junction, for the dissection of loci underlying phenotypic variation. Genome-wide association
analysis is used to identify regions of the genome which harbor variants that have large effects
on phenotypic variation and gene expression studies are used to identify transcripts which dif-
fer in abundance between individuals which differ in phenotype. When these data are inte-
grated, differentially expressed (DE) genes which reside in genomic regions that have been
shown to be trait-associated suggests a direct role for these genes in regulating trait variation
[10–12].
The identification of bovine genes and networks which influence host biological response to
bacterial and viral infections is an important step towards identifying the specific genetic vari-
ants within the bovine genome which enable the establishment of infection and reduce the effi-
cacy of immune responses. These variants may be directly selected in livestock populations to
reduce the prevalence of multi-agent diseases such as BRDC. The aim of this research was to
compare, relative to controls, the bronchial lymph node transcript levels of steers produced
from Angus bulls mated to advanced generation Hereford-Angus crossbred cows that were
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experimentally challenged with IBR, BVDV, BRSV,M. haemolytica, P.multocida orM. bovis.
Bronchial lymph nodes were chosen for analysis because the immune response to pathogens in
the lung is important to the host response and these nodes contain lymphocytes that come
from the lung. Moreover, these nodes are where antigen presentation occurs and where the T
and B cells are stimulated. Consequently, bronchial lymph nodes provide the best window into
lymphocyte responses within the infected lung compartment.
Materials and Methods
Animal ethics statement
This study was specifically approved by the Institutional Animal Care and Use Committee of
the University of California at Davis with animal use protocol #16424.
Animal sampling and challenge
The sampling of the experimental animals and the design and implementation of the challenge
experiment are described in a companion paper. Briefly, steers produced by mating Angus
sires to advanced generation Angus-Hereford crossbred dams were obtained from the Sierra
Field Station of the University of California Davis located in Brown’s Valley, CA. Blood was
collected and steers seronegative, or with the lowest titers against each bacterial and viral path-
ogen, were selected. The six to eight month old steers were transported to the University of Cal-
ifornia Davis where they were maintained in pens, fed a 65% concentrate starter diet and were
provided water ad libitum. The challenge studies were performed sequentially starting with the
control animals and with animals housed in groups by control or challenge pathogen. Strict
biosecurity protocols were employed including a period between experimental challenges to
prevent cross-infection.
Two experiments were conducted during the summers of 2011 and 2012, comprising an ini-
tial pilot project designed to determine the conditions for optimization of the challenge experi-
ment and the final optimized challenge experiment, respectively. Optimized doses
administered to groups of N = 4 animals challenged with one of the following viruses (BRSV,
BVDV and IBR) via a nebulizer or bacteria (M. haemolytica, P.multocida andM. bovis) admin-
istered by intratracheal tube inserted directly into the mid-trachea were: BRSV (1.6 × 105/
ml × 8.5 ml/animal), IBR (1.0 × 107/ml × 8.5 ml/animal), BVDV (2.0 × 108/ml × 8.5 ml/ani-
mal);M. haemolytica (4.8 × 1011 CFU/animal), P.multocida (1.13 × 1011 CFU/animal) andM.
bovis (7.0 × 1010 CFU/animal). In addition, two control animals were aerosol administered
with 8.5 ml of tissue culture media via a nebulizer and two additional control animals were
inoculated by intratracheal instillation with 8.5 ml of phosphate buffered saline. The volume of
phosphate buffered saline given by intratracheal inoculation was followed by two volumes of
air to make sure that no saline was left in the tube; whereas, the tissue culture media was given
by aerosol to mimic one mechanism of viral exposure. One animal challenged withM. bovis
was euthanized early due to extreme disease and tissues were not collected, leaving 27 animals
with bronchial lymph node tissues available for analysis from the optimized study. Strains were
obtained as follows: BRSV—Dr. Laurel Gershwin, University of California, Davis (CA-1); IBR
—California Animal Health and Food Safety Laboratory, clinical isolate (ATCC, lot: VR188
LA); BVDV—Dr. Chris Chase, South Dakota State University (890);M. haemolytica
(89020807N) and P.multocida (232)—Dr. Anthony Confer, Oklahoma State University;M.
bovis (428E)—Dr. Ricardo Rosenbush, Iowa State University.
Clinical scores were recorded daily from 3 days before challenge until euthanasia using a
scoring system based on a combination of systems described elsewhere [13–15]. None of the
animals were considered to require treatment with analgesics or anesthetics and these were not
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provided. Steers were necropsied when clinical signs were determined to have peaked but with
the exception of the animal challenged withM. bovis that was euthanized early, these were not
considered to be humane end-points. Animals were euthanized on days 7, 15, 6, 5, 15 and 6
post-challenge, when clinical signs had peaked for BRSV, BVDV, IBR,M. haemolytica,M.
bovis and P.multocida, respectively. After the steers were euthanized, lungs and other viscera
were removed for examination by a certified veterinary pathologist. Larynx, trachea, bronchi,
and lungs were examined and lesions were recorded to estimate consolidation levels.
RNA isolation and sequencing
One milliliter of Trizol Reagent (Invitrogen, Carlsbad, CA) was added to 50–100 mg of frozen
bronchial lymph node sample, which was immediately homogenized. Samples were centri-
fuged at 12,000 g for 10 min at 4°C and 200 μl of chloroform was added after transferring the
aqueous layer to a fresh tube. After another centrifugation at 12,000 g for 10 min at 4°C, RNA
from the aqueous layer was precipitated first with 500 μl of isopropanol and then washed with
1 mL of 75% ethanol. The pellet was dissolved in 100 μl DEPC water and placed at 4°C over-
night. The following day, the RNA sample was DNase1 treated to remove potential contamina-
tion from genomic DNA. RNA purity and concentration was established using a NanoDrop
1000 v1.3.2 (Thermo Scientific, Wilmington, DE). The absence of RNA degradation was first
assessed by electrophoresis of 1 μg of RNA on a 1.0% agarose gel. Finally, the quality of each
RNA sample was evaluated using an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa
Clara, CA) with an RNA NanoChip.
Preparation of the mRNA samples for sequencing was performed by Global Biologics
(Columbia, MO) using the TruSeq RNA Sample Preparation Kit (Illumina1, San Diego, CA)
and 10 μg of total RNA from each bronchial lymph node. Polyadenylated RNA was purified
from the total RNA using oligo dT magnetic beads, then fragmented with divalent cations
under elevated temperature. First strand cDNA synthesis was accomplished using random hex-
amer primers followed by second strand synthesis. Double-stranded cDNA underwent end
repair and the 3’ ends were adenylated. Finally, universal adapters were ligated to the cDNA
fragments and solid phase PCR was performed to produce the sequencing library. Following
library construction, each sequencing library was evaluated using an Agilent 2100 Bioanalyzer
and equimolar amounts from each library were pooled to create 5 pools which were individu-
ally sequenced (2 × 50 bp) on one lane of a HiSeq 2000 instrument with the exception of pool 5
which was sequenced (2 × 50 bp) on two lanes. An error in library pooling resulted in low
sequence coverage for one individual for which additional 2 × 100 bp reads were generated.
These reads were trimmed to 2 × 50 bp prior to analysis.
The sequence data were submitted to the National Center for Biotechnology Information
Sequence Read Archive under accession number SRP052314. S1 Table contains the sample
identification for the RNA-Seq data that corresponds to each of the experimentally challenged
animals.
Processing of sequence reads
Sequence reads were filtered for quality and adapter sequences were trimmed using a custom
Perl script that identifies exact string matching to a user-supplied adapter sequence as
described in [16].
Read alignment
Computations were performed on the HPC resources at the University of Missouri Bioinfor-
matics Consortium (UMBC). TopHat v2.0.6 [17] was used to align the trimmed reads to the
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Bos taurus virtual transcriptome build and the UMD3.1 reference genome by providing both a
transcript file and the reference genome assembly. TopHat first extracted transcript sequences
and used Bowtie to align reads to the virtual transcriptome build. The reads that could not be
mapped to the virtual transcriptome were next mapped to the genome assembly. These reads
were converted to genomic mappings (spliced as necessary) and merged with the novel tran-
scriptome mappings and junctions. A total of 2 mismatches were allowed in alignment.
Transcript assembly and quantification
Cufflinks v2.0.2 [18] was used to assemble the aligned reads into a parsimonious set of tran-
scripts for each sample individually. Cufflinks treated regions of the genome that were covered
by sequence reads as potential exons and used the mapped junctions to assemble transcripts.
Cufflinks also estimates transcript abundances as Fragments Per Kilobase of exon per Million
fragments mapped (FPKM), which normalizes transcript expression for transcript length and
the total number of sequence reads per sample. The reference annotation supplied to Cufflinks
was used to guide the reference annotation-based transcript assembly. The output included all
reference transcripts as well as any novel assembled genes and isoforms.
Testing for differential expression
Cufflinks assemblies for all of the samples were merged using Cuffmerge v2.0.2 which also
runs Cuffcompare to annotate the merged assembly and filter a number of transfrags that are
likely to be artifacts. The available annotation file was provided to enable the merging of assem-
bled contigs into novel and known isoforms and to maximize the overall quality of the assem-
bly. The reference annotation file was used downstream in Cuffdiff to estimate gene expression
levels for each exposure group and to test these groups for DE genes. P-values were corrected
for multiple testing (q value) using the Benjamini-Hochberg correction [19]. Cuffdiff estimates
the FPKM for each transcript, primary transcript, and gene in each sample. The FPKM values
for all genes were used to construct a multidimensional scaling (MDS) plot to investigate the
relationships between samples and the within- and between-challenge group gene expression
profiles. From among the DE genes, the 200 with the largest FPKM variances across all biologi-
cal replicates were used to construct a heatmap by hierarchical clustering analysis. All data
exploration and visualization was performed using the CummeRbund package [18] imple-
mented in the R environment.
Annotation of differentially expressed genes
The Database for Annotation, Visualization, and Integrated Discovery (DAVID) v6.7 [20] was
used to annotate and interpret the DE gene lists produced by Cuffdiff. DAVID software identi-
fies enriched biological themes and gene ontology (GO) terms and clusters functionally related
genes and annotation terms for gene lists with EASE scores< 0.1. The Functional Annotation
Tool was used to determine the most relevant GO terms within each DE gene list. The Func-
tional Annotation Clustering algorithm was used to generate a report of related annotation
terms and groups of annotation clusters. DAVID Pathway was also used to map genes onto
pathways enriched for DE genes.
The Ingenuity Pathway Analysis software (IPA; http://www.ingenuity.com) was also used to
discover and explore biological processes and the roles of DE genes. The Ingenuity Pathways
Knowledge Base synthesizes relationships such as those between genes, mRNAs and proteins
and can be used to identify networks and pathways with an overrepresentation of DE genes.
Immunological Response to Single Pathogen Challenge with BRDC Agents
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Results
Sequencing throughput, read alignment and assembly
To obtain insights into the molecular basis of immune response in Angus × Hereford steers
experimentally challenged with bacterial or viral pathogens most commonly associated with
BRDC, we first searched for bronchial lymph node transcript abundance variation among the
23 challenge and four control animals. In this process, we discovered that one of the control
animals failed to cluster with the other three biological control replicates in the MDS plot (PC1
vs PC2) and, consequently, it was excluded from the analysis (data not shown). We generated
an average of 49,360,049 (2 × 50 bp) paired-end reads for each sample and the overall read
alignment rate achieved by TopHat ranged from 78.7 to 87.5%.
Alignment files from TopHat were provided to Cufflinks to create a transcriptome assembly
for each animal and these were then merged across all animals using Cuffmerge. The identifica-
tion of full-length isoforms from incompletely reconstructed fragments is not generally reliable
without experimental confirmation. Moreover, assembly errors occur and accumulate when
several assemblies are merged [21]. Because these RNA-seq data were from a relatively well-
annotated organism, and the number of potential novel isoforms appeared to be very large
(68.33% of the identified transcripts; Table 1), we chose to not use the merged assembly file in
the downstream Cuffdiff analysis to avoid the potential for bias caused by assembly errors [21].
The large number of potentially new isoforms was expected because most human multi-exon
genes are known to undergo alternative splicing [22]. We manually evaluated 100 potentially
new isoforms by randomly sampling transcripts within different size ranges and searching the
NCBI ‘nr’ database for these sequences with BLAST and observed that 76% were new isoforms,
8% were likely assembly artifacts, 10% represented incompletely assembled reference genes
(i.e., missing exons or possessing larger 3’ or 5’ end sequences) and 6% had retained introns.
Quality control and exploration of relationships between challenge
groups
To evaluate data quality, we first performed an analysis in which pairwise comparisons were
made between all animals challenged with bacteria vs controls, all animals challenged with
viruses vs control and all animals challenged with bacteria vs all animals challenged with
Table 1. Transcript Classifications Reported by Cuffmerge for the Merged Assemblies.
Cufflinks Class Description No. of
transcripts
%
Complete match of intron chain 25,197 28.45
A transfrag falling entirely within a reference intron 72 0.08
Potentially novel isoform (fragment) 60,526 68.33
Single exon transfrag overlapping a reference exon and at least 10 bp of a
reference intron
0 0.00
Generic exonic overlap with a reference transcript 1,323 1.49
Possible polymerase run-on fragment 1 0.00
An intron of the transfrag overlaps a reference intron on the opposite strand 0 0.00
Exonic overlap with reference on the opposite strand 1,294 1.46
Repeat 0 0.00
Multiple classifications 0 0.00
Unknown, intergenic transcript 166 0.19
Total 88,581 100
doi:10.1371/journal.pone.0131459.t001
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viruses. The Cuffdiff output was also examined for reliability using several quality control
methods. First, the variation between biological replicates was assessed using an MDS plot
based on all expressed genes, which revealed a strong clustering of samples from control, bacte-
rially and virally challenged animals with little variation between replicates (Fig 1). The first
dimension clearly separated the virus- from the bacteria-challenged and control animals, while
the second dimension separated controls from bacteria- and virus-challenged animals and sug-
gests an ordering of pathogenicity. This postulate was also supported by the Jensen–Shannon
divergence statistics between the challenged groups estimated from FPKM values for all genes
(Fig 2) and by the principal component analysis (PC1 vs PC2; Fig 3), which show that the per-
turbation of gene expression was greatest for the animals challenged with viruses. The dynamic
range of FPKM values was also evaluated by creating a boxplot of log10 transformed FPKM val-
ues for each biological replicate (Fig 4). The median FPKM values across the challenge groups
were similar and the ranges indicate that our depth of sequence coverage was sufficient to
allow the identification of genes with low transcript abundance.
Differential expression and functional annotation
Differential expression analysis was performed separately for each pathogen challenge group in
contrast to the control group to provide insights into pathogen-specific immune response.
These analyses identified from 329 DE genes for theM. bovis vs control comparison to 4,123
for the IBR vs control comparison and the sign of the log2(fold change) was used to partition
DE genes into up- and down-regulated groups (Table 2).
The functional annotation analysis performed by DAVID for the DE genes found in the
comparison of the BRSV challenged to control animals (S2 Table), revealed pathways related
Fig 1. Multidimensional scaling plot of samples based on all genes. Legend: bact_0, bact_1 and bact_2
areM. bovis challenged; bact_3, bact_4, bact_5 and bact_6 are P.multocida challenged; bact_7, bact_8,
bact_9 and bact_10 areM. haemolytica challenged; virus_0, virus_1, virus_2 and virus_3 are BRSV
challenged; virus_4, virus_5, virus_6 and virus_7 are BVDV challenged and virus_8, virus_9, virus_10 and
virus_11 are IBR challenged animals.
doi:10.1371/journal.pone.0131459.g001
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to brain diseases such as Parkinson’s, Huntington’s and Alzheimer’s. Additionally, pathways
related to proteasome, oxidative phosphorylation, pyrimidine and purine metabolism, RNA-
polymerase, spliceosome, cell adhesion molecules, EMC-receptor interaction, Wnt signaling,
cytokine-cytokine receptor interaction and leukocyte transendothelial migration were identi-
fied as being enriched for DE genes along with other pathways with known roles in immune-
response (S2 Table). The top five canonical pathways identified by IPA were oxidative phos-
phorylation (p8.97E-22), mitochondrial dysfunction (p4.15E-20), protein ubiquitination
(p3.06E-11), role of macrophages, fibroblasts and endothelial cells in rheumatoid arthritis
(p3.24E-09) and glucocorticoid receptor signaling (p2.33E-08). The upstream pathway reg-
ulators were predicted by IPA based upon the consistency of the direction of gene expression
changes within the pathways enriched for DE genes (S3 Table). The most important upstream
regulators predicted for the response to BRSV challenge included: lipopolysaccharide (LPS),
tretinoin, TNF, TGFB1 and beta-estradiol. With the exception of tretinoin, for which the acti-
vation state was not predicted; all other regulators were predicted to be activated in the chal-
lenged animals (and therefore inhibited in controls; S3 Table).
DAVID analysis of DE genes identified in the BVDV challenged vs control animals, revealed
pathways for ECM-receptor interaction, focal adhesion, lysosome, complement and coagula-
tion cascades, cell adhesion molecules, leukocyte transendothelial migration, cancer associated
pathways, VEGF signaling, toll-like receptor signaling, TGF-beta signaling, MAPK signaling,
and T cell receptor signaling (S4 Table). The IPA identified the hepatic fibrosis/hepatic stellate
cell activation (p5.41E-17), acute phase response signaling (p3.14E-13), role of osteoblasts,
osteoclasts and chondrocytes in rheumatoid arthritis (p1.36E-11), IGF1 signaling (p5.83E-
Fig 2. Heatmap showing the Jensen–Shannon (JS) divergence between challenge groups estimated from FPKM values for all genes.
doi:10.1371/journal.pone.0131459.g002
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11) and leukocyte extravasation signaling (p2.47E-09) pathways. The five most significant
upstream regulators were predicted to include PPBP (TGB1), TNF, IRF6 (LPS), TP53 and dexa-
methasone (S5 Table). While the activation status of TNF was not determined, all other regula-
tors were activated in the challenged animals.
For the IBR challenged animals, DAVID analysis revealed similar pathways to those found
for the BRSV and BVDV challenges, with a few exceptions (S6 Table). However, the IPA iden-
tified the role of macrophages, fibroblasts and endothelial cells in rheumatoid arthritis
(p2.38E-11), role of osteoblasts, osteoblasts and chondrocytes in rheumatoid arthritis
(p5.15E-10), B cell receptor signaling (p3.81E-09), acute phase response signaling
(p4.65E-09) and PI3k signaling in B lymphocytes (p1.7E-08) as enriched for consistently
regulated DE genes. The five most significant upstream regulators identified as controlling
these processes were the same as those identified for the BVDV challenged animals (S7 Table).
Similar pathways to those found for the virus challenges were found for the animals chal-
lenged with the bacterial pathogens. In animals challenged withM. haemolytica, DAVID iden-
tified pathways enriched for DE genes including ECM-receptor interaction, focal adhesion, cell
adhesion molecules, chemokine signaling, antigen processing and presentation, toll-like recep-
tor signaling, primary immunodeficiency, T cell receptor signaling, natural killer cell mediated
cytotoxicity and TGF-beta signaling (S8 Table). Pathways related to hepatic fibrosis/hepatic
stellate cell activation (p1.28E-21), granulocyte adhesion and diapedesis (p1.65E-17),
agranulocyte adhesion and diapedesis (p8.84E-15), type I diabetes mellitus signaling
(p1.7E-08) and role of macrophages, fibroblasts and endothelial cells in rheumatoid arthritis
(p4.12E-08) were identified by IPA. The most significant upstream regulators identified by
Fig 3. Principal component analysis for gene-level features.
doi:10.1371/journal.pone.0131459.g003
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IPA were essentially the same as reported for the virus challenges (S9 Table), however, IFNG
and IL4 regulators were also predicted. Only the activation statuses of TGFB1 and IFNG could
be predicted, which were activated and inhibited in challenged animals, respectively.
The DAVID and IPA results for theM. bovis (S10 Table) and P.multocida (S11 Table) chal-
lenges were similar to those forM. haemolytica. However, differences were found among the
most significant of the upstream regulators (S12 and S13 Tables, respectively). For example,
IL1B was identified for the M. bovis challenge. Furthermore, dexamethasone and beta-estra-
diol, previously identified as being among the most important upstream regulators for the
BVDV and BRSV challenges, were also found to be important regulators for response to P.
multocida challenge. In general, the activation statuses of these regulators could not be deter-
mined; however, TGFB1 and dexamethasone were predicted to be activated in P.multocida
challenged animals.
We found 5,757 unique genes to be DE relative to the controls across all pathogen challenge
groups. From this list of genes, we identified the 200 DE genes with the greatest variance in
FPKM values across all biological replicates and used them to perform a hierarchical clustering
analysis based upon gene expression (Fig 5). This analysis was able to correctly cluster the bio-
logical replicates for BRSV, IBR, and the controls, while clusters for IBR andM. haemolytica
each contained a member from a different challenge pathogen and replicates forM. bovis and
P.multocida were not well clustered. This is consistent with the finding that these challenge
groups had the fewest DE genes (Table 2) since the strategy for gene sampling primarily
selected genes with large expression variances which tended to be drawn from the challenge
groups with the largest number of DE genes (Table 3). Of the 200 genes, 25 were DE in all chal-
lenge groups (Table 3), indicating that these genes are predictive of infection regardless of
Fig 4. Dynamic range of FPKM values represented as log10 transformed FPKM values for each gene
calculated for each biological replicate. Legend: bact_0, bact_1 and bact_2 areM. bovis challenged;
bact_3, bact_4, bact_5 and bact_6 are P.multocida challenged; bact_7, bact_8, bact_9 and bact_10 areM.
haemolytica challenged; virus_0, virus_1, virus_2 and virus_3 are BRSV challenged; virus_4, virus_5,
virus_6 and virus_7 are BVDV challenged and virus_8, virus_9, virus_10 and virus_11 are IBR challenged.
doi:10.1371/journal.pone.0131459.g004
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specific etiology. However, several among these 200 genes were exclusive to a single pathogen
challenge, and these genes are of significant biological interest for understanding the bovine
pathogen-specific immune response, and are likely to be useful for predicting pathogen-specific
infections among cattle within various production environments.
While some pathways enriched for DE were shared among several of the pathogen chal-
lenges, different genes appeared to be responsible for their regulation. For example, pattern-
recognition receptors may be pathogen-specific. To examine this, we compared the DE genes
enriched within the toll-like receptor pathway in both the IBR andM. haemolytica challenges.
Table 2. Numbers of Up- and Down-Regulated Differentially Expressed Genes and Isoforms for each
Challenge Group in Contrast to Controls.
No. of Differentially Expressed Genes
Comparison Up-regulated Down- regulated
BRSV vs control 1,543 1,942
BVDV vs control 1,560 1,758
IBR vs control 2,071 2,052
M. haemolytica vs control 960 1,393
M. bovis vs control 126 203
P. multocida vs control 366 778
doi:10.1371/journal.pone.0131459.t002
Fig 5. Heatmap for 200 differentially expressed genes with the greatest fold differences from all pathogen challenges using hierarchical clustering
analysis. Hierarchical clustering of gene expression profiles in all samples. Each row represents a gene and each column an animal. The extent of
expression of each gene in each sample is indicated by a color code. The color key ranges from saturated red for log2 ratios less or equal to -5.0 to saturated
yellow for log2 ratios greater than or equal to 10. Red indicates an increased gene expression in the challenged animals. Legend: bact_0, bact_1 and bact_2
areM. bovis challenged; bact_3, bact_4, bact_5 and bact_6 are P.multocida challenged; bact_7, bact_8, bact_9 and bact_10 areM. haemolytica
challenged; virus_0, virus_1, virus_2 and virus_3 are BRSV challenged; virus_4, virus_5, virus_6 and virus_7 are BVDV challenged and virus_8, virus_9,
virus_10 and virus_11 are IBR challenged.
doi:10.1371/journal.pone.0131459.g005
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Although some genes were in common, the activation or inactivation of signaling pathways
appears to be caused by the regulatory mechanisms of specific downstream transcription fac-
tors (Fig 6).
Recently, a GWAS has reported 116 genomic regions associated with BRDC susceptibility
in Holstein calves which had been naturally exposed to the pathogens responsible for disease
[23]. The 1 Mb regions flanking each QTL harbor 649 annotated candidate genes, of which,
142 were found to be DE in our analysis, with 27 identified as potential upstream regulators
likely responsible for the transcriptional changes detected in pathways enriched for DE genes
(S14 Table). Some of the QTL regions contain at least six genes that were DE in response to
multiple challenge pathogens and at least one of the genes was predicted to be an upstream reg-
ulator. In particular, the QTL regions from 107–108 Mb on BTA3, 67–68 Mb on BTA13, 30–
31 Mb on BTA15, 72–73 Mb on BTA17 and 55–56 Mb on BTA18 harbor from 6 to 16 genes
that were DE in animals challenged by all pathogens except forM. bovis. The QTL region from
65–66 Mb on BTA18 harbors 10 DE genes for which the upstream predicted regulators
BCL2-Associated X Protein (BAX) and Protein Phosphatase 1, Regulatory Subunit 15A
(PPP1R15A) were located in the syntenic QTL region at 55–56 Mb. The 10 genes in this QTL
region were found to only be DE in response to challenge by the three viral pathogens.
Discussion
Efforts have been made to decrease the use of antibiotics in livestock production and to find
alternative methods to control disease. Global gene expression analyses have been used to iden-
tify prognostic signatures in humans, i.e., for the discovery of gene sets that may predict patient
outcomes relative to treatment for a specific cancer [24,25]. BRDC is caused by the interaction
of stressors which are often temporally coincident with natural exposures to viral and bacterial
agents which collectively lead to the manifestation of clinical signs and lung pathology. How-
ever, each pathogen may trigger a specific immune response. The RNA sequencing approach
adopted in this study provides an expression pattern of genes that may be helpful for predicting
whether a pathogen-specific immune response mechanism is activated and for the develop-
ment of new therapeutic treatment options (i.e., drugable targets).
Since BRD is multifactorial and can be caused by a number of pathogens individually or as
co-infections [26], determination of disease etiology can be difficult. We found both common
Table 3. Differentially Expressed Genes with the Largest Expression Variances by Challenge Group.
Pathogen Challenge Genes
All pathogens ACTG2, CTHRC1, CXCL9, GP2, HERC6, IFI44, IFIT1, IFIT3, ISG15, MMP9,
OAS1, PGLYRP1, PI16, RAPGEF5, RSAD2, S100A8, S100A9, SFRP2, SFRP4,
SLC6A15, TF, TGM3, ULBP3, VCAN and ZBP1
At least two viral
pathogens
FOSB, GFRA2, GZMB, NUPR1, WSCD2, AIRE, BPI, CDHR1, CHODL,
CLEC10A, EDIL3, ESR2, IFITM3 and MCHR1
At least two bacterial
pathogens
CDH10, DGAT2, MMP13, PAMR1, PLAC8, PLIN4, PRSS35, MGAM, MGAT3,
ADC, FABP7, MAL2, OLFM4 and SEMA3C
BRSV FRZB, MT1E, NPTX1, TSPAN18 and CA4
BVDV ALB, ITIH2, KRT24, MMP7 and TTR
IBR AHNAK, ASZ1, BST2, CD1B, KCNE1L, LILRA4, PLCXD3, RNF24 and
TMEM213
M. haemolytica BMPR1B, COL6A6, KIR3DL2, LYNX1, MAD2, PF4, PRND, SOSTDC1, TDRD1
and TRIL
M. bovis EBD and TSPAN1
P. multocida ACOX2, ACSM1, BTNL9, CYP1A1, FABP4, GSTT3, SIX1, TECTB and TUSC5
doi:10.1371/journal.pone.0131459.t003
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and pathogen-specific differences in the bronchial lymph node transcriptome profiles of ani-
mals challenged with viruses and bacteria known to be common causes of BRD. The DE genes
and pathways that were found to be common to all pathogen challenges were up-regulated in
the challenged animals and appear to primarily be related to the innate immune response,
Fig 6. Differentially expressed genes enriched within the toll-like receptor pathway. A. IBR challenged animals.B.M. haemolytica challenged animals.
Red stars indicate the differentially expressed genes in each pathway.
doi:10.1371/journal.pone.0131459.g006
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which enables a rapid antimicrobial host defense prior to the development of the adaptive
immune response. This was consistent with the sampling of steers for the challenge experiment
which had either no, or low, blood titers against the challenge pathogens. However, the innate
immune system may also be involved in determining which antigens the acquired immune sys-
tem responds to and the manner of that response [27].
We identified several pathways which underlie the immune response mechanisms that are
induced following infection. The innate immune system, which responds to all pathogens, rec-
ognizes pathogen-associated molecular patterns (PAMPs) by host pattern-recognition recep-
tors (PRRs). The list of PRRs which are known to sense PAMPs is extensive, and includes
members of at least four gene families: Toll-like receptors (TLRs), nucleotide oligomerization
domain like receptors, C-type lectin receptors and retinoic acid-inducible gene I like receptors.
PRR ligation stimulates several signaling pathways that result in the activation of nuclear fac-
tor-κB, mitogen-activated protein kinases (MAPKs) and interferon regulatory factors, which
mediate the production of cytokines and type I interferons needed for an effective innate
response [28–32]. The pro-inflammatory state that results from these mechanisms is necessary
for the generation of a robust antimicrobial environment and for the appropriate stimulation
of the adaptive immune response [32].
The common pathways underlying response to two or more of the challenge organisms
include pathways with major roles in innate immunity that are less pathogen-specific. For
example, we found the toll-like receptor pathway and MAPK signaling which are responsible
for the phosphorylation and activation of kinases which regulate cytokine production [33],
TGF-beta signaling, which functions in cytokine regulation [34] and natural killer cell medi-
ated cytotoxicity whereby populations of lymphocytes are activated to cytotoxicity via the pro-
duction of cytokines and chemokines [35]. The cytokine and chemokine-related pathways
were all up-regulated in the challenged animals. Cytokines and chemokines have important
functions in the innate and adaptive immune systems. The production of cytokines by innate
immune cells occurs as an acute response to inflammation and infection across diverse etiolo-
gies. The release of cytokines and chemokines orchestrates immune responses through com-
munication with other cells. For the immune response to efficiently function, the synthesis and
release of cytokines must be controlled [36] and the pathways enriched for DE genes detected
in our analyses of these data are involved in this process. It is important to note that cytokines
underlying the control of viral immunity differ from those that are most relevant to anti-bacte-
rial defense. For example, an effective immune response to BRSV, IBR and BVDV requires the
development of cytotoxic T cells, which are critical for the elimination of virus infected cells.
Production of interleukin 12 and interferon gamma by T helper type 1 cells facilitates the prim-
ing of CD8 cytotoxic T cells. Whereas, in humoral immunity, antibody production is associated
with interleukin 4 expression and interleukin 17 stimulates a neutrophil response in the
defense against many bacterial pathogens [37].
Despite the finding of common pathways enriched for DE genes across challenge pathogens,
different genes appear to be responsible for pathway activation. For example, the DE genes that
are enriched in the toll-like receptor pathway differ for the IBR challenged andM. haemolytica
challenged groups (Fig 6). In response to theM. haemolytica challenge, TLR1 and TLR6 are
induced while for IBR, TLR2 and TLR4 are induced. TLR2 and TLR4 proteins are present on
the surface of immune cells and are known to be involved in the recognition of several viruses
via the detection of envelope glycoproteins [38]. The activation of TLRs initiates downstream
signaling cascades which regulate intracellular kinases and may stimulate an inflammatory and
an antigen-specific immune response. The signaling pathways associated with each TLR differ
and may involve different biological responses [39]. Our results suggest that TLR1 and TLR6
Immunological Response to Single Pathogen Challenge with BRDC Agents
PLOS ONE | DOI:10.1371/journal.pone.0131459 June 29, 2015 14 / 21
mediate the innate immune response toM. haemolytica while TLR2 and TLR4mediate
response to infection by IBR and other viruses.
We also detected evidence of adaptive immune response mechanisms, in particular the
enrichment of DE genes within the B and T cell receptor signaling pathways. Lymphocytes can
recognize a large number of different antigens including bacteria, viruses, and other disease-
causing organisms [37]. While B cells are critical for the humoral immune response, T helper
cells are important for initiation of the humoral response to T dependent antigens. T lympho-
cytes are also involved in cell-mediated immune responses, both as T helper type 1 cells and as
cytotoxic T cells. B cell-related pathways were not detected in response to challenge by any of
the bacterial agents which is puzzling because the development of an antibody response usually
occurs for infections by each of the bacterial pathogens. Presumably these were induced early
in the response to challenge and had abated by the time the animals were euthanized. However,
the IPA results revealed that pathways related to B cell receptors were among the most impor-
tant in the animals’ responses to virus challenge.
In addition to the B cell receptor signaling pathway, which was induced only for the virus
challenges, pathways including the regulation of actin cytoskeleton, ErbB signaling, RNA poly-
merase and degradation, VEGF signaling and oxidative phosphorylation related to mitochon-
drial activity were also important for response to viral infection. Some of these pathways have
clear roles in immune response, e.g., regulation of the actin cytoskeleton has a crucial role in
important cellular processes required for normal immune function, including locomotion,
intercellular interactions, endocytosis, signal transduction and maintenance of cell morphology
[40] and oxidative phosphorylation which is required for memory T cell metabolism [41]. We
also found pathways related to brain diseases [42] in the IPA of the DE genes in animals chal-
lenged with BRSV which have a key role in mammalian immune response through the regula-
tion of apoptosis during infection. In the DAVID analysis of this gene set, the most enriched
functional clusters were mitochondrial and oxidative phosphorylation (S2 Table). Mitochon-
dria have recently been recognized as having an important role in the innate immune response
against viral pathogens [32].
Neurodegenerative disease-related pathways including Huntington’s, Parkinson’s and Alz-
heimer’s diseases were induced in the animals challenged with BRSV and IBR. There are many
shared genes between these 3 pathways that relate to neurological disease. For example, all
three include the activation of COX5A and COX5B which are cytochrome C oxidase subunit
enzymes in the mitochondrial respiratory chain and defects in mitochondrial function are
associated with all three diseases. However, activation of these genes by BRSV and IBR is not
likely to be associated with neurological disease in infected cattle. Rather, our findings suggest
that neurologic interference may be a common manifestation of infection by pathogenic
viruses. A recent study found that neurodegenerative disease-related pathways were induced in
HIV-infected peripheral blood mononuclear cells [43]. Potential upstream regulators of these
pathways and their target molecules were identified in our analyses (S3, S5, S7, S9, S12 and S13
Tables) and this information may be useful for the development of novel therapeutics. IPA
upstream regulator analysis attempts to identify the cascade of upstream transcriptional regula-
tors that are responsible for the observed gene expression changes [44] and whether they are
likely activated or inhibited.
LPS was identified as an upstream regulator in the response to challenge by all pathogens
and agents leading to LPS stimulation may provide new therapy options for the prevention of
respiratory diseases in cattle. LPS treatment is known to activate the innate immune response
and induce interferon-stimulated genes and proinflammatory cytokines in hepatocytes, inhib-
iting, for example, hepatitis B virus replication [45]. Our results indicate that LPS also seems to
induce a cascade of antiviral genes [46] in addition to antibacterial genes. The LPS activated
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immune response to bacterial infection results in the production of NKT cells and IFNγ [47].
Additionally, TNF, which was also identified as an upstream regulator of gene expression
response to all challenge pathogens may also deserve consideration in the development of
treatment options which regulate immune cells. Anti-TNF is currently being used to treat
human inflammatory and autoimmune diseases, for example, rheumatoid arthritis. Use of this
drug has been associated with decreased immune responses to a variety of pathogens [48,49].
Twenty five of the 5,757 DE genes were common to all pathogen challenges (Table 3) and
function in clusters of secreted and extracellular proteins such as the ubiquitin-like modifier
ISG15, which is induced by IFN-α/β and plays an essential role in innate immunity against
viral and bacterial infections [50], Tf which is important to cell proliferation through the supply
of iron for DNA synthesis [51],MMP9 which is an important protease that is involved in the
breakdown of the extracellular matrix and leukocyte recruitment [52] and CXCL9 which is
involved in T cell trafficking [53]. Further, the myeloid-related protein encoded by S100A9
which is a calcium and zinc binding protein has a role in the inflammatory and immune
response and is up-regulated in peripheral blood mononuclear cells of severe acute respiratory
syndrome patients [54]. It can enhance neutrophil adhesion, chemotaxis, and bactericidal
activity and may be an interesting target for genetic selection.
Hierarchical clustering using FPKM values for all biological replicates for the 200 DE genes
with the largest expression variances across biological replicates was nearly capable of correctly
clustering all replicates into their respective challenge groups (Fig 5). P.multocida was an
exception and the challenge with this pathogen was not ideal, sinceM. bovis was also isolated
from the lungs of these challenged animals. Despite this, we have identified bronchial lymph
node gene expression signatures which characterize the immune response and are predictive of
the pathogens responsible for BRDC in cattle.
The difficulty in achieving a single infection with any of the BRDC pathogens was under-
scored in this study by our use of commercial animals. Cultures of the upper respiratory tract
from the steers revealed the expected common bacterial pathogens. However, culture of lungs
from these steers predominantly demonstrated the pathogen that was introduced by experi-
mental challenge. Our selection of the bronchial lymph node for RNA sequencing was based
upon the fact that lymphocytes within the node drain the lung and therefore their RNA expres-
sion represents a response to pathogens in the lung [55]. Thus, lymphocyte responses to bacte-
rial agents found in the upper respiratory tract, where they normally occur as commensals,
were not expected to be observed in transcripts from the bronchial lymph nodes.
Many DE expressed genes are located in previously identified QTL regions associated with
risk of BRD in Holstein calves [23]. Among these are several key upstream regulators which
are predicted to regulate the expression of numerous downstream genes that were DE between
challenged and control animals. Polymorphisms within regulatory elements controlling the
expression of these genes and their isoforms or within the primary transcripts themselves are
strong candidates for the detected QTL. Due to the difference in breeds between this and the
GWAS [23] and because animals in this study were randomly assigned to challenge groups
without regard to their BRD susceptibility, the transcript variants for the DE genes reported in
S14 Table do not inherently provide strong candidates for the causal variants underlying the
QTL. Rather, variant detection using genomic DNA from cases and controls drawn from the
GWAS population offers the greatest likelihood of identifying the causal variants.
Summary and Conclusions
The majority of DE genes discovered in this study were up-regulated in the challenged animals
and involved with innate immunity regardless of disease etiology. Among these genes were
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those coding for pattern-recognition receptors which appear to stimulate the same metabolic
pathways. A set of the 200 most variable of the DE genes was able to partially classify each rep-
licate into its respective challenge group and may be useful for predicting the immunopatho-
genesis of disease caused by each pathogen and the effects that genetic manipulation might
have on disease outcomes. Key upstream regulators were identified which provide possible tar-
gets for the development of novel molecular therapies and studies exploring the effects of
manipulating their signaling on the modulation of bovine immune function should be consid-
ered. One hundred and forty two DE genes, some of which are key upstream regulators were
found to be located in previously identified QTL regions associated with risk of BRD. Our anal-
yses of these data provide new insights and perspectives into the genetic basis of BRDC suscep-
tibility and the molecular mechanisms underlying bovine immune responses to respiratory
disease which may be useful for the identification of large effect loci underlying differential sus-
ceptibility and for the development of new therapeutic intervention strategies.
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